AVN 63.69 Decreased By ▼ -4.01 (-5.92%)
BOP 8.78 Decreased By ▼ -0.46 (-4.98%)
CHCC 134.50 Decreased By ▼ -3.50 (-2.54%)
DCL 10.05 Decreased By ▼ -0.53 (-5.01%)
DGKC 108.00 Decreased By ▼ -4.60 (-4.09%)
EFERT 64.45 Decreased By ▼ -0.35 (-0.54%)
EPCL 41.30 Decreased By ▼ -2.45 (-5.6%)
FCCL 21.00 Decreased By ▼ -0.26 (-1.22%)
FFL 15.05 Decreased By ▼ -0.76 (-4.81%)
HASCOL 15.08 Decreased By ▼ -0.62 (-3.95%)
HBL 131.10 Decreased By ▼ -3.90 (-2.89%)
HUBC 81.62 Decreased By ▼ -2.58 (-3.06%)
HUMNL 7.40 Decreased By ▼ -0.51 (-6.45%)
JSCL 24.29 Decreased By ▼ -1.81 (-6.93%)
KAPCO 28.35 Decreased By ▼ -0.79 (-2.71%)
KEL 3.71 Decreased By ▼ -0.12 (-3.13%)
LOTCHEM 11.75 Decreased By ▼ -0.24 (-2%)
MLCF 41.85 Decreased By ▼ -0.46 (-1.09%)
OGDC 93.33 Decreased By ▼ -3.02 (-3.13%)
PAEL 32.92 Decreased By ▼ -1.48 (-4.3%)
PIBTL 12.86 Decreased By ▼ -0.48 (-3.6%)
PIOC 95.00 Decreased By ▼ -4.00 (-4.04%)
POWER 9.77 Decreased By ▼ -0.30 (-2.98%)
PPL 83.60 Decreased By ▼ -2.36 (-2.75%)
PSO 200.00 Decreased By ▼ -6.89 (-3.33%)
SNGP 56.60 Decreased By ▼ -2.94 (-4.94%)
STPL 13.15 Decreased By ▼ -0.05 (-0.38%)
TRG 46.60 Decreased By ▼ -3.13 (-6.29%)
UNITY 23.00 Increased By ▲ 0.76 (3.42%)
WTL 1.05 Decreased By ▼ -0.02 (-1.87%)
BR100 4,133 Decreased By ▼ -155.2 (-3.62%)
BR30 21,019 Decreased By ▼ -858.48 (-3.92%)
KSE100 39,888 Decreased By ▼ -1298.86 (-3.15%)
KSE30 16,750 Decreased By ▼ -546.72 (-3.16%)
COVID-19 TOTAL DAILY

TOKYO: Sony Corp is selling its 5% stake in Olympus Corp back to the Japanese medical equipment maker for 80.4 billion yen ($762.88 million), a move that Daniel Loeb's activist hedge fund Third Point LLC had called for.

This is the first strategic move Sony has made that is in line with US-based Third Point's proposals since Loeb, one of the world's highest-profile activist investors, revealed earlier this year he was building a stake again in the company.

A Sony spokeswoman said the sale was not in response to demand by specific shareholders, adding that the company is still reviewing Third Point's proposals.

Sony will sell 68.9 million Olympus shares at Thursday's closing price of 1,165 yen by participating in Olympus' share buyback plan.

Sony bought 11.5% of Olympus in 2012-13, paying 50 billion yen in a much-needed cash injection for the latter after an accounting scandal sent Olympus' share price plummeting. Sony later halved its stake to finance its own restructuring.

The companies have developed high-definition surgical endoscopes and microscopes through a medical equipment joint venture established in 2013.

Sony said in a statement it decided to sell "considering that the initial purpose of the capital alliance to establish collaboration between Sony and Olympus has been accomplished and after reviewing the rationale for owning the Olympus shares."

Loeb has called on Sony to spin off its semiconductor business and sell off stakes in Sony Financial, Spotify and other non-core assets, in order to position itself as a leading global entertainment company.

"Sony's valuation discount is attributable primarily to portfolio complexity, which will be a permanent problem unless it is decisively addressed," Third Point said in a letter to investors in June.

Shares of Sony have risen 23% since early April, when Reuters reported that Loeb was building a stake in the company to push for change. The effort marks the second time in six years that Loeb has targeted Sony.

Copyright Reuters, 2019